These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 35483665

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. GALNT3 protects against phosphate-induced calcification in vascular smooth muscle cells by enhancing active FGF23 and inhibiting the wnt/β-catenin signaling pathway.
    Guo L, Wang Y, Li S, Zhou L, Li D.
    Cell Signal; 2022 Dec; 100():110477. PubMed ID: 36162588
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Klotho/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b/β-catenin pathway.
    Chen YX, Huang C, Duan ZB, Xu CY, Chen Y.
    Kaohsiung J Med Sci; 2019 Jul; 35(7):393-400. PubMed ID: 31001900
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. BMP9/COX-2 axial mediates high phosphate-induced calcification in vascular smooth muscle cells via Wnt/β-catenin pathway.
    He F, Wang H, Ren WY, Ma Y, Liao YP, Zhu JH, Cui J, Deng ZL, Su YX, Gan H, He BC.
    J Cell Biochem; 2018 Mar; 119(3):2851-2863. PubMed ID: 29073723
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Differing calcification processes in cultured vascular smooth muscle cells and osteoblasts.
    Patel JJ, Bourne LE, Davies BK, Arnett TR, MacRae VE, Wheeler-Jones CP, Orriss IR.
    Exp Cell Res; 2019 Jul 01; 380(1):100-113. PubMed ID: 31004580
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Sirtuin-1 and Its Relevance in Vascular Calcification.
    Lu CL, Liao MT, Hou YC, Fang YW, Zheng CM, Liu WC, Chao CT, Lu KC, Ng YY.
    Int J Mol Sci; 2020 Feb 26; 21(5):. PubMed ID: 32111067
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Unspliced XBP1 Counteracts β-Catenin to Inhibit Vascular Calcification.
    Yang L, Dai R, Wu H, Cai Z, Xie N, Zhang X, Shen Y, Gong Z, Jia Y, Yu F, Zhao Y, Lin P, Ye C, Hu Y, Fu Y, Xu Q, Li Z, Kong W.
    Circ Res; 2022 Jan 21; 130(2):213-229. PubMed ID: 34870453
    [Abstract] [Full Text] [Related]

  • 35. Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2.
    Liang X, Li Y, Wang P, Liu H.
    PeerJ; 2024 Jan 21; 12():e18063. PubMed ID: 39308809
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease.
    Li W, Feng W, Su X, Luo D, Li Z, Zhou Y, Zhu Y, Zhang M, Chen J, Liu B, Huang H.
    J Clin Invest; 2022 Jan 04; 132(1):. PubMed ID: 34793336
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.